Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
By 104 weeks, approximately 77% of SELECT patients on dose were receiving the target semaglutide 2.4 mg weekly dose, which is lower than the corresponding proportion of patients in STEP 1 (89.6% were receiving the target dose at week 68) 14,21
Animal studies confirmed AOD9604s fat-reducing potential
The peptide mechanism creates a cascade that promotes lipolysis without affecting blood sugar regulation or triggering the growth-promoting pathways associated with full growth hormone
Efficacy vs
US$ 22.76
US$ 21.70
US$ 29.41
US$ 24.04
US$ 22.08
US$ 25.29
